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Abstract 
 Residual renal function has been reported to be a major determinant of 
peritoneal dialysis technique survival for patients with end stage kidney disease. 
Anuria, leads to increases in peritoneal dialysis (PD) prescriptions designed to 
maintain small solute clearances and ultrafiltration volumes, resulting in greater 
exposure to hypertonic glucose dialysates. We reviewed the effect of 
developing anuria in a cohort of 136 PD patients followed for a median of 12 
months, to determine whether increasing exposure to higher glucose dialysates 
affected body composition by increasing body fat and reducing muscle mass. 
Despite increasing prescription of 22.7 g/l and 38.6 g/l glucose dialysates there 
was no increase in body fat (31.1±15.4 vs 30.9±16.3 kg) or loss of fat free weight 
(36.4 ±12.1 vs 35.8 ±12.3 kg). 
 Changing PD prescriptions to maintain small solute clearances and 
ultrafiltration volumes did not lead to detrimental changes in body composition 
in the short term. 
 
Introduction 
 More than three hundred thousand patients with end stage kidney failure 
are treated by peritoneal dialysis worldwide. After peritonitis [1] loss of 
residual renal function and reliance on peritoneal dialysis to achieve adequate 
ultrafiltration is the next most common cause of technique failure and transfer 
to haemodialysis [2].  
 Ultrafiltration in peritoneal dialysis is achieved through an osmotic 
gradient created by using higher dextrose dialysate concentrations or an 
oncotic gradient using isomaltose (icodextrin) containing dialysate. As such 
anuric peritoneal dialysate patients are typically prescribed more glucose 
containing dialysates once residual renal function has been lost. It has been 
suggested that the increased mortality associated with loss of residual renal 
function may be due to protein energy wasting (PEW), secondary to increased 
glucose absorption from the peritoneal dialysates with loss of appetite and 
reduced protein intake [3]. 
 To determine whether anuric peritoneal dialysis patients develop PEW we 
determined changes in body composition in a cohort of patients using multi-
frequency bioelectrical impedance assessments (MFBIA).  
   
Patients and methods 
 We compared the first MFBIA after patients were documented to have 
become anuric (urine output < 100 ml/day) with a follow up assessment. 136 adult 
patients treated by peritoneal dialysis under the care of two tertiary university 
hospitals at clinical dry weight between Aug 2008 and Jan 2012 were reviewed. 
All patients had MFBIAs performed in a standardised manner (BCM Fresenius, 
Bad Homberg, Germany, InBody 720, Seoul South Korea),  as part of established 
routine clinical care [4,5]. We have previously derived equations comparing these 
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devices [5,6], and assessed reproducibility of measuring fat mass (Bland Altman 
mean bias 0.04 kg). Although both Baxter (Baxter Health Care, Deerfield, USA) 
and Fresenius  peritoneal dialysis systems were used, the majority  were treated 
with Baxter peritoneal dialysis systems. 
24 hour effluent peritoneal dialysate and urine collections were analysed 
to determine urine volume and both peritoneal clearances and residual renal 
function, and normalised nitrogen appearance (nPNA) to assess dietary protein 
intake calculated by standard methods, and all patients underwent peritoneal 
transport assessment.  
Ethical approval was granted by the local ethical committee as audit and 
clinical service development.  
 
Statistical analysis 
 Statistical analysis was by single or paired analysis, students’ t tests, 
Mann Whitney U test, or Wilcoxon pair analysis, with appropriate correction for  
multiple analyses, and by Chi square test with Yate’s correction (GraphPad Prism 
version 6.0, San Diego, USA). Data are presented as mean ± standard deviation, 
median (inter quartile range) or as a percentage. 
 
Results 
136 patients, median age 59.9 ±14.3 years, 54.4 % male, 35.3% diabetic, 
31% Caucasoid, 36% South Asian and 27% African/Afro-Caribbean were 
studied. The median peritoneal dialysis vintage at time that anuria was 
documented was 11.8 months (9.0-48.8), and the median time between 
assessments 11.8 (10-13) months. 36% were treated by continuous ambulatory 
peritoneal dialysis and 64% by automated peritoneal dialysis cyclers (APD). On 
follow up the percentage of patients prescribed icodextrin, and higher dialysate 
glucose solutions increased from 44.1 to 63.9%, and for 22.7 g/l glucose (120 
mmol/l) 58 to 78.2% and for ≥ 38.6% glucose (204 mmol/l) 29 to 46% (all 
p<0.05). Dialysis adequacy as assessed by weekly peritoneal urea clearance and 
ultrafiltration volumes did not differ (Table 1). Nor did dietary protein intake as 
assessed by nPNA, despite the increased prescription of higher glucose 
containing dialysates (Figure 1), body composition measured by MFBIA did not 
change for the cohort (Table 1), or on subgroup analysis. 
 
Discussion 
To compensate for the loss of residual renal function, peritoneal dialysis 
prescriptions are typically adjusted in clinical practice to increase both 
peritoneal small solute clearances and ultrafiltration, leading to larger infill 
volumes and additional cycles, with greater use of hypertonic glucose dialysates 
[3]. In keeping with this practice there was a greater prescription of both 
hypertonic glucose dialysates and icodextrin in our cohort of anuric patients 
maintained on peritoneal dialysis.  
 Previous reports have suggested that hunger profiles are blunted in 
peritoneal dialysis patients compared to both haemodialysis patients and normal 
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healthy controls [8], as appetite may be reduced by a variety of factors 
including abdominal distension from larger in-fill volumes, and increased glucose 
absorption from hypertonic glucose dialysates. As such earlier studies reported 
reduced nutritional intake over time in anuric patients [4], and those patients 
with greater malnutrition, determined by subjective global assessment scoring 
were more likely to die or transfer to haemodialysis [3]. Despite changes in 
peritoneal dialysis prescriptions and exposure to greater amounts of dialysate 
glucose our cohort of patients did not reduce their dietary protein intake, as 
assessed by nPNA. We used MFBIA to determine body composition, as previous 
studies have shown correlation with body composition measured by dual X-ray 
absorption scanning [9]. Although increased dialysate glucose exposure could 
potentially lead to increased absorption leading to an increase in body fat, and a 
reduced appetite in combination with the uraemic state lead to protein energy 
wasting [10], we observed no increase in body fat or reduction in muscle mass in 
this cohort of anuric peritoneal dialysis patients followed for a median of a year. 
 Our data which shows stable body composition over twelve months 
suggests that peritoneal dialysis can be a successful therapy for chronic kidney 
failure patients despite a loss of residual renal function. Previous reports have 
suggested that both peritoneal dialysis adequacy, in terms of small solute 
clearances and ultrafiltration volumes may be important in determining 
peritoneal dialysis technique failure [2,]. However studies have varied in small 
solute clearances and daily ultrafiltration volumes to be clearly able to define a 
minimum target for every day clinical practice. Our patients achieved acceptable 
targets for both small solute clearances and ultrafiltration volumes [2] but 
lower levels may have resulted in PEW and technique failure. Our study was too 
small to identify an effect of age, sex, ethnicity and diabetes, and our cohort 
was also potentially biased as a survivor cohort, but even so despite increasing 
exposure to higher glucose based dialysates we did not show any detrimental 
changes to body composition, with patients maintaining both fat and muscle mass 
despite becoming anuric.  
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Figure 1: change in peritoneal dialysis prescription of 7.5% icodextrin and 22.7 
g/l and ≥ 38.6 g/l glucose dialysates in  peritoneal dialysis who had been 
recorded as being anuric, median peritoneal dialysis vintage 11.8 months (9.0-
48.8),  and then peritoneal dialysis prescription at time of repeat bioimpedance 
after a median follow up of 11.8 months. *** p <0.001 
 6 
Table 1. Peritoneal dialysis adequacy, daily ultrafiltration volume, assessment of 
protein intake by normalised nitrogen accumulation (nPNA) and body composition 
from multifrequency bioelectrical impedance. No significant differences. 
 
 anuric on follow up 
weekly peritoneal Kt/Vurea 1.89 ±0.43 1.83 ±0.35 
24 hr peritoneal ultrafiltration volume ml 942 (600-1371) 950 (639-1374) 
nPNA g/kg/day 0.81 ±0.22 0.86 ±0.16 
body mass index kg/m2 24.4 ±4.3 24.6 ±4.8 
intracellular water litres 18.25±4.79 18.02 ± 4.76 
fat mass kg 31.1 ±15.4 30.9 ±16.3 
fat free mass kg 36.4 ±12.1 35.8 ±12.3 
 
 
 
